Clinical Trials in Austin

Showing 5161-5180 of 15,205 trials

Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS

NCT05196828

Multi-center, prospective open-label extension study of noninvasive peripheral nerve stimulation (NPNS) with the NTX100 Neuromodulation System for patients with medication-refractory moderate- severe primary RLS

Restless Legs Syndrome

Noctrix Health, Inc.103 participantsStarted Dec 2021

San Leandro, California, United States • Colorado Springs, Colorado, United States • Atlanta, Georgia, United States +4 more locations

TERMINATEDPhase 2< 1 mile

A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

NCT05567783

The purpose of this study is to evaluate the efficacy, safety, and tolerability of VIR-2482 compared to placebo in preventing influenza A illness in healthy adults 18 to \<65 years of age without pre-existing risk factors for serious complications from influenza infection.

Influenza A

Vir Biotechnology, Inc.2,977 participantsStarted Oct 2022

Anniston, Alabama, United States • Mobile, Alabama, United States • Tempe, Arizona, United States +48 more locations

Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS

A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

Find Trials by Condition in Austin

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer

Palbociclib in Real World Practice

Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors

A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma

Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)

A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study

A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1

Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease

PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)

Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis

Acupuncture for Preterm Infants Requiring Eye-exam

Target Controlled Infusion Using Propofol and Remifentanil for Moderate Sedation in Dentistry